RORa (Retinoid-related Orphan Receptor) is a transcription factor belonging to the superfamily of nuclear receptors. The spontaneous staggerer (sg) mutation, which consists of a deletion in the Rora gene, has been shown to cause the loss of function of the RORa protein. The total loss of RORa expression leads to cerebellar developmental defects, particularly to a dramatic decreased survival of Purkinje cells and an early block in the differentiation process. This review focuses on recent studies which position RORa as a pivotal factor controlling Purkinje cell survival and differentiation, from development to ageing.
Introduction
Staggerer (Rora sg ) is a spontaneous null mutation consisting of a deletion in the gene encoding the nuclear receptor RORa. Both RORa-deficient micehomozygous staggerer mutant mouse (Rora sg/sg ) and transgenic mice in which the Rora gene has been disrupted (Rora 2/2 ) -display a severe ataxic phenotype associated with a strong cerebellar hypoplasia, a consequence of the degeneration of a large majority of Purkinje cells during development and the consequent absence of virtually all granule cells (1, 2) . Interestingly, the few surviving Purkinje cells display immature shapes and abnormal differentiation. Moreover, both Purkinje cell survival and differentiation have been shown to be also abnormal in aged heterozygous staggerer mutants (Rora +/sg ), indicating a crucial role for RORa in these processes from development to ageing. This review focuses on the recent findings which contribute to a better understanding of the role of RORa in the cerebellar development, and particularly in the Purkinje cell survival and differentiation throughout development and ageing.
The nuclear receptor RORa
RORa (Retinoic acid receptor related Orphan Receptor a, also called NR1F1) (3) is a member of the nuclear receptor superfamily, which includes receptors for thyroid and steroid hormones, retinoids and vitamin D (4, 5) . RORa has long been considered as an orphan receptor, constitutively active in the absence of exogenous ligand (6, 7) . However, RORa has since been shown to be activated by abundant intracellular cholesterol (8) .
RORa is composed of the characteristic nuclear receptor domains ( Figure 1 ). RORa has an aminoterminal domain (A/B region), a DNA binding domain (DBD or C region, conserved domain among the members of the nuclear receptors family), a hinge (D region) and a ligand binding domain (LBD or E region). The LBD contains a carboxy-terminus activation function domain (AF-2), responsible for ligand dependant transcriptional activation. The DBD, composed of two zinc finger motifs and a carboxy-terminal extension (CTE), is involved in the recognition of DNA response elements. The ROR response element (RORE) sequence is composed of a 6-base pair A/T-rich region immediately preceding a consensus AGGTCA motif (9) (10) (11) . RORa interacts as a monomer with RORE sequence within the promoter regions of target genes, but RORa is also able to bind as a homodimer at direct repeats of the RORE site separated by two base pairs, or DR2 sites (12, 13) .
By a combination of promoter usage and alternative splicing, the Rora gene gives rise to four isoforms in human, RORa1, a2, a3 and RORa4 (also termed RZRa), while only a1 and a4 isoforms have been detected in the mouse (14) (15) (16) . These isoforms differ in their N-terminal modulator region, which interacts with A/T-rich sequences of the RORE and thus permits distinct promoter recognition and transactivation properties through an identical DNA binding domain (DBD) (9, 14) . Functionally active RORE have been identified in a number of putative target genes, but the functional regulation by RORa in vivo remains to be demonstrated for many of them. Micro-array analyses of the cerebellar transcriptome in staggerer mutants followed by chromatin immunoprecipitation experiments identified authentic RORa target genes in the cerebellum, including genes involved in calcium signal transduction (Pcp2, Pcp4, Itpr1) and the mitogenic factor Sonic Hedgehog (Shh) (17) .
RORa expression
RORa is a widely expressed nuclear receptor. RORa has been detected in many tissues including brain, thymus, skeletal muscle, skin, heart, vessels, liver, lung, gut, kidney tubules, whisker follicles and pancreas (15, (18) (19) (20) . In the brain, in situ hybridization and immunohistochemical analyses revealed Rora expression in the cerebellum, in olfactory bulb, hippocampus, thalamus, cerebral cortex (mainly in layer IV), suprachiasmatic nuclei of the hypothalamus and retinal ganglion cells (18, 21, 22) . In the cerebellum, RORa mRNA and protein have been detected at high levels in Purkinje cells (from age E13) and at lower level in stellate and basket interneurones ( Figure 2 ) (22) .
RORa loss-of-function mutant mice
The homozygous staggerer mutant mouse displays a strong ataxic phenotype due to a massive cerebellar atrophy ( Figure 2 ). The staggerer mutation has been identified as a 6.5-kb genomic deletion within the Rora gene, corresponding to a single 122-bp exon deletion in the mRNA, which removes the start of the LBD (see Figure 1A ) and shifts the reading frame, causing a stop codon 27 residues later. The staggerer mutation thus prevents the translation of the LBD of the RORa protein, involving the lack of any transcriptional activity (19, 23) .
Two strains of mice lacking a functional RORa (Rora 2/2 transgenic mice) have been generated, by using a targeting vector in which a LacZ gene replaces the second zinc finger of the DBD of RORa (18) or by inserting a neomycin cassette in the first zinc finger of the DBD (24) .
The strong decrease in Rora sg allelic mRNA (19) , together with the similar cerebellar phenotype displayed by both Rora sg/sg and Rora 2/2 mutants (18, 24, 25) , suggests that the staggerer mutation is a null mutation and thus leads to the loss of function of RORa.
Studying the staggerer phenotype has led to the discovery of many putative functions of RORa. From the first identification of the developmental cerebellar defect in homozygous staggerer mutants in 1962 (1), the role of RORa has since been expanded beyond the cerebellum, in particular in the control of circadian rhythms through the transcriptional regulation of BmalI (26) (27) (28) (29) (30) . Moreover, outside the central nervous system, RORa has been shown to be implicated in the development of many tissues and in the differentiation process of many cell types, and provides protection against age-related degenerative processes including osteoporosis, atherosclerosis and chronic inflammation (for review, see 31, 32) .
Proliferative and neuroprotective function of RORa in the cerebellum
Mutant mice lacking functional RORa protein (18, 19 ) display a massive cerebellar degeneration (1): most of the Purkinje cells degenerate (82% are lost at two months of age (25)) while granular cells are virtually all absent (33) in homozygous staggerer mutants. According to Vogel and collaborators, Purkinje cells die between the postnatal (P) day 0 and P5 (34) . In the other parts of the brain, cell losses have been reported only in the olfactory bulb in the staggerer mutant mice (35) .
To determine whether the effect of the staggerer mutation was direct (intrinsic) or indirect (extrinsic), staggerer v5w wild-type chimeras were made by aggregating two embryos at the 8-cell stage of development. Analyses of these staggerer chimeras demonstrated that the Purkinje cell loss was a direct consequence of the cell-autonomous action of the staggerer mutation (36) , which is consistent with the distribution of RORa mRNA and protein in the cerebellum, where only Purkinje cells and interneurones have been shown to express RORa (19, 22, 37) .
The granule cell loss has been shown to occur as a dual consequence of the PC loss. First, the study of the developmental persistence of the external granular layer (EGL) together with the study of the postmitotic granular cell population in staggerer chimeras suggested that the reduced number of granule cells due to the staggerer mutation were the result of both reduced granule cell genesis and increased cell death (38) . These hypotheses, based on the study of chimeras, have been confirmed recently by a molecular analysis of target genes of RORa in the cerebellum (17) . Microarray analyses of the developing Rora sg/sg cerebellar transcriptome have shown a decreased expression of proliferation markers, while Shh has been identified as a RORa target gene in the cerebellum (17) . Quantification of BrdU incorporation revealed a decreased granular cell proliferation in Rora sg/sg organotypic cultures compared to wild-type. Moreover, adding Shh in the mutant slice preparations could restore normal proliferation of granule cell precursors in Rora sg/sg slices (17), confirming a crucial role of Shh in the granule cell proliferation (39) . An indirect loss of almost 60% of the cells within the inferior olivary complex in Rora sg/sg mutants has been also described (40) (41) (42) .
The neurodegeneration in Rora sg/sg mutants is accompanied by a chronic inflammatory state. Interestingly, stimulation of peripheral macrophages of Rora sg/sg mutants by lipopolysaccharide (LPS) induces an abnormally high amount of pro-inflammatory cytokines IL-1, IL-6 and TNFa (43) . In addition, Rora sg/sg mice are more susceptible to LPSinduced airway inflammation in the lung (44) , and RORa has been reported to inhibit inflammatory responses in vascular smooth muscle cells (45) . The anti-inflammatory role of RORa might be mediated in some tissues through the direct transcriptional control of the I-kBa gene, an inhibitor of the NF-kB transcription factor (45) . Moreover, abnormal IL-1b cytokine production has been also described in the staggerer brain after peripheral LPS treatment (46) , demonstrating a general condition of hyperexcitability which could increase the neurodegeneration.
The mutation was initially described as recessive, since heterozygous Rora +/sg mutants are behaviourally normal, without cell loss in the young adult. However, a Purkinje cell loss of about 25-35% appears afterwards and mostly between 6 and 12 months of age (47) (48) (49) , whereas in control, Purkinje cell loss begins at 18 months to reach 25% at 24 months of age (49) . The Purkinje cell loss in the Rora +/sg mutant is accompanied by both granule cell (35%) and olivary neuron (30%) degeneration (47,50). Interestingly, although the level of Rora
Purkinje cell survival is similar between males and females at 13 months, the time-course of the loss depends on the sex in Rora +/sg mutants. In males, the Purkinje cell loss starts from 1 month and continues regularly up to 13 months. In contrast, in females, Purkinje cell number remains stable up to 9 months of age, then decreases to the same number as males (49) . These data indicate that Rora +/sg heterozygous mutants undergo a more precocious Purkinje cell loss during ageing. Moreover, unlike controls, in which the later age-related Purkinje cell loss occurs similarly between males and females, the Purkinje cell loss time-course is influenced by the sex in Rora +/sg animals. Half-dose loss of functional RORa has thus revealed an influence of gender in Purkinje cell survival during ageing.
These results show that RORa function is essential for Purkinje cell survival during development and ageing. Whereas half-dose of functional RORa protein seems to be sufficient to allow Purkinje cell survival during development, Rora +/sg mutant PCs are not protected against age-associated injuries. Among these, an increased vulnerability to oxidative stress is thought to play a critical role in age-related cell death (reviewed in (51) (52) (53) . The oxidative stress homeostasis is known to play a crucial role in the neuronal survival. The Harlequin (Hq) mutation, which disrupts the Apoptosis-Inducing Factor (AIF) gene, leads to an increased oxidative stress in brain (54) . Interestingly, a progressive granular cell loss has been reported in the cerebellum of Hq/Hq mutants, suggesting a critical role of the anti-oxidant defenses in the neuronal survival during ageing.
To test whether an increased RORa expression could be neuroprotective, we have recently developed a recombinant lentiviral vector to perform RORa overexpression in cultured neurons. The survival rate of RORa-overexpressing cortical neurons was evaluated in response to different stressors disturbing redox homeostasis, such as Ab peptide, c 2 -ceramide and H 2 O 2 (55) . In this study, we have shown that lentiviral-mediated hRORa1-overexpression provides neuroprotection against reactive oxygen species (ROS)-induced apoptosis. Downregulation of Gpx1 or Prx6 by si-RNA experiments partially suppressed the RORa-mediated neuroprotection, further demonstrating that this protection is, at least in part, mediated by an up-regulation of the anti-oxidant enzymes glutathione peroxidase 1 and peroxiredoxin 6, which leads to a decrease of the oxidative stress in neurons. RORa appears thus as a factor controlling the oxidative stress in neurons (55) .
We can therefore propose a model in which the age-related increased Purkinje cell loss in Rora +/sg animals could be linked to the loss of the antioxidant actions of RORa, whereas in wild type animals the activity of RORa might reduce the effects of oxidative stress, thus leading to a relative neuroprotection during ageing compared to that observed in the heterozygous staggerer mutant. Further studies will be needed to determine whether the observed Purkinje cell loss is linked to an increased ROS production in Rora +/sg mutants. Although the homozygous staggerer phenotype has been described for the first time in 1962 (1), the mechanism of Purkinje cell death in this mutant is still unknown. Interestingly, several studies have proposed the existence of a developmental Purkinje cell death period, occurring around P3 (56) (57) (58) (59) (60) . An increased ROS production is thought to be involved in developmental cell death, such as in trophic factor starvation during development (61) . In Rora sg/sg mice, Purkinje cell loss seems to occur during this period (34) . We may hypothesize that RORa's control of cellular oxidative damage such as those induced by trophic deprivation renders it essential for Purkinje cell survival during development.
More generally RORa seems to be involved in the cellular stress response network. It has been shown that hypoxia up-regulates expression of the Rora gene, which is a target for HIF-1 that acts upon binding to an hypoxia response element (HRE) in its promoter (62) . Moreover, an increased expression of the Rora gene in cells exposed to a variety of different cellular stresses, including H 2 O 2 (63) has been reported. This strongly suggests that RORa is involved in the response to different stress such as hypoxia and oxidative stress, by regulating a subset of genes involved in the control of oxidative stress.
Oxidative stress is also associated with the progression of neurodegeneration in several pathologies including Alzheimer's and Parkinson's diseases, and spinocerebellar ataxia. Interestingly, a tie between RORa and spinocerebellar ataxia type 1 (SCA1), a polyglutamine repeat expansion disorder, has been proposed in a recent review (64) : recent data indicates that RORa may bind ataxin-1 directly and that RORa expression levels are decreased in the SCA1 model. Oxidative stress has been shown to increase the cell death in cellular models of SCA1 (65) . The decreased expression of RORa in this model could result in decreased antioxidant actions, which would promote the cell death. It should be noticed that RORa may intervene in human spinocerebellar ataxia also by other mechanisms: it has been shown recently that RORa1 was repressed by expanded ataxin-7, the abnormal protein of the spinocerebellar ataxia type 7 (66).
RORa, a crucial factor controlling early PC differentiation
Most of the Purkinje cells degenerate in the Rora sg/sg cerebellum, but, interestingly, those that survive display immature features. Purkinje cells are in an embryonic state: somata appear smaller than controls (33) (Figure 2 ), while dendrites are rudimentary and stunted, lacking distal spiny branchlets (67) (68) (69) . Before their target-related cell death in the Rora sg/sg cerebellum (2), granule cells which have been generated seem to differentiate normally. By electronic microscopy, the presence of attachment plates between Purkinje cell dendrites and parallel fibers has been described (70) , suggesting that parallel fibers form transient primitive junctions with the Purkinje cell dendritic shaft, but attachment plates then fail to develop into functional synapses (70) . In contrast, qualitatively normal dendritic spines and synapses are formed with climbing fibers (33, (67) (68) (69) . However, there is a failure in the developmental regression of the Purkinje cell polyinnervation by climbing fibers (71, 72) . Other immature and embryonic features remain in the postnatal Rora sg/sg cerebellum, such as the persistent expression of embryonic cell surface components (73, 74) like embryonic NCAM isoforms (75) . Moreover, expression of the late Purkinje cell markers Pcp-2/L7 (19) and calmodulin (76) , which normally increases during development, have been shown to be altered in Rora sg/sg mice. All these studies have suggested that the differentiation of the surviving Rora sg/sg Purkinje cells is impaired. However, in Rora sg/sg , the neurodegeneration begins just after birth, which renders identification of exact Purkinje cell differentiation abnormalities very difficult. Indeed, Purkinje cell differentiation is known to be dependent upon granular cell interaction (77) (78) (79) (80) . The differentiation of Rora sg/sg Purkinje cells has been studied in dissociated (81) or cerebellar organotypic (82) cultures, in which the differentiation can be observed independently of the neurodegeneration. In both culture types, Purkinje cells display an early postnatal block of the differentiation process, as they did not progress beyond the embryonic shape reminiscent of their migratory morphology (81, 82) . More precisely, we have shown that Purkinje cells from newborn Rora sg/sg cerebella do not undergo the normal regression of embryonic processes; these primitive processes continuing to develop rather than regress, as happens in wild-type Purkinje cells in cerebellar slices (82) and in vivo (83) . Indeed, Purkinje cells, like other neurons, regress their embryonic bipolar processes prior to developing their ultimate dendritic tree (83) . We have further demonstrated that RORa expression is crucial for the early steps of Purkinje cell differentiation, as lentiviral-mediated hRORa1 overexpression in wildtype Purkinje cells led to the acceleration of the early steps of differentiation, in particular the first step of dendritic regression (82) . Moreover, hRORa1 expression in Purkinje cells in Rora sg/sg cerebellar slices could restore the normal differentiation progression. These results demonstrate that RORa is a crucial factor controlling early postnatal Purkinje cell differentiation.
In addition to the differentiation abnormalities described in vivo in the developing cerebellum of homozygous Rora sg/sg mice, others have been described in the ageing cerebellum of heterozygous Rora +/sg mutants (84) . The effects of the ageing process are apparent in the wild-type Purkinje cell as a dendritic atrophy is observed at 24 months of age. However, in Rora +/sg mutants, there is a considerably accelerated dendritic atrophy compared to controls, which is detected as early as 4 months of age in Rora +/sg but not until 22 months in Rora +/+ . The regression of the dendritic arbor not only starts earlier in Rora +/sg than in Rora +/+ , but it is also much more extensive (84) . The dendritic atrophy does not seem to be the intracellular consequence of the cell death since dendritic atrophy is still observed after 13 months of age, when the Purkinje cell number does not decrease anymore. However, dendritic atrophy could be an indirect consequence of Purkinje cell death: the resulting granular cell loss in the cortex leads to the loss of the input from the parallel fibers on Purkinje cells which is known to influence dendritic arborization. Nevertheless, in view of the demonstrated role of RORa on the early dendritic differentiation, we can hypothesize that RORa also plays a role in the maintenance of the dendritic arborization during ageing. Further studies will be needed to determine whether RORa could play such a role.
Conclusion
The nuclear receptor RORa, which plays a major role in the development of many tissues throughout the organism, appears to be a pivotal nuclear receptor for cerebellar development and ageing, in particular through its effect on Purkinje cell survival and differentiation.
During development, RORa expression is crucial for the Purkinje cell survival and differentiation. At the level of granule cells, RORa plays a dual role: first, it directly controls their genesis by controlling their proliferation in the EGL through Shh, and second, RORa is indirectly necessary for their survival since granule cells undergo target-related cell death in the absence of Purkinje cells. In the adult, RORa protects Purkinje cells against agerelated deleterious effects and RORa is involved in the maintenance of dendritic arborization of Purkinje cell during ageing.
